kynurenine has been researched along with Eosinophilia-Myalgia Syndrome in 4 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Eosinophilia-Myalgia Syndrome: A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a L-tryptophan-induced case of eosinophilia-myalgia syndrome in a Japanese woman and describe the time course of changes in tryptophan metabolism observed during steroid therapy." | 7.69 | Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome. ( Hisatomi, A; Imamura, T; Kubota, A; Nagata, T; Nawata, H; Ohashi, M; Umeda, F, 1997) |
| "To investigate the metabolism of L-tryptophan (LT) via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome (EMS)." | 7.68 | Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. ( Harati, Y; Heyes, MP; McKinley, K; Quearry, B; Silver, RM; Smith, EA; Sternberg, EM, 1992) |
| "The eosinophilia-myalgia syndrome (EMS) was associated with ingestion of L-tryptophan containing products and was accompanied by altered metabolism of L-tryptophan during the active phase." | 7.68 | Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. ( Carreira, P; Heyes, MP; Silver, RM; Sutherland, SE, 1992) |
| "Abnormal metabolism of tryptophan is one of the possible aetiological factors in the L-tryptophan-induced eosinophilia-myalgia syndrome (EMS)." | 7.68 | L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine. ( Fathi, M; Mainetti, C; Saurat, JH, 1991) |
| "We report a L-tryptophan-induced case of eosinophilia-myalgia syndrome in a Japanese woman and describe the time course of changes in tryptophan metabolism observed during steroid therapy." | 3.69 | Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome. ( Hisatomi, A; Imamura, T; Kubota, A; Nagata, T; Nawata, H; Ohashi, M; Umeda, F, 1997) |
| "To investigate the metabolism of L-tryptophan (LT) via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome (EMS)." | 3.68 | Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. ( Harati, Y; Heyes, MP; McKinley, K; Quearry, B; Silver, RM; Smith, EA; Sternberg, EM, 1992) |
| "The eosinophilia-myalgia syndrome (EMS) was associated with ingestion of L-tryptophan containing products and was accompanied by altered metabolism of L-tryptophan during the active phase." | 3.68 | Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. ( Carreira, P; Heyes, MP; Silver, RM; Sutherland, SE, 1992) |
| "Abnormal metabolism of tryptophan is one of the possible aetiological factors in the L-tryptophan-induced eosinophilia-myalgia syndrome (EMS)." | 3.68 | L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine. ( Fathi, M; Mainetti, C; Saurat, JH, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisatomi, A | 1 |
| Kubota, A | 1 |
| Ohashi, M | 1 |
| Umeda, F | 1 |
| Nawata, H | 1 |
| Imamura, T | 1 |
| Nagata, T | 1 |
| Silver, RM | 2 |
| McKinley, K | 1 |
| Smith, EA | 1 |
| Quearry, B | 1 |
| Harati, Y | 1 |
| Sternberg, EM | 1 |
| Heyes, MP | 2 |
| Sutherland, SE | 1 |
| Carreira, P | 1 |
| Mainetti, C | 1 |
| Fathi, M | 1 |
| Saurat, JH | 1 |
4 other studies available for kynurenine and Eosinophilia-Myalgia Syndrome
| Article | Year |
|---|---|
Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
Topics: Anti-Inflammatory Agents; Eosinophilia-Myalgia Syndrome; Female; Humans; Kynurenine; Middle Aged; Pr | 1997 |
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.
Topics: Adrenal Cortex Hormones; Adult; Aged; Eosinophilia-Myalgia Syndrome; Female; Humans; Interferon-gamm | 1992 |
Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
Topics: Arthritis, Rheumatoid; Biopterins; Brassica; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsatur | 1992 |
L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Hydroxyindoleacetic Acid; Kynurenine; Middle A | 1991 |